Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Infectious Diseases

Open Access

Risk assessment studies on HLA association with drug induced hypersensitivity caused by anti tuberculosis drugs – an in silico approach

BMC Infectious Diseases201414(Suppl 3):P45

https://doi.org/10.1186/1471-2334-14-S3-P45

Published: 27 May 2014

Background

Studies have conferred that there is a strong genetic association between HLA alleles and susceptible drugs leading to hypersensitivity. Patients with HIV have the highest risk of developing active Tuberculosis. So here we studied the genetic predisposition to anti-tuberculosis drugs as a model to study the pathological role of HLA alleles in drug hypersensitivity.

Method

Here we aimed to find out the anti-tuberculosis drugs like sulfasalazine, allopurinol, streptomycin and oflaxacin as candidate drugs and their binding sites on HLA alleles which are prevalent among Indian population like HLA-A*02:06, HLA-B*57:01, HLA-A*02:01 and HLA-A*02:03 using docking simulation method via Autodock.

Result

Anti-tuberculosis drugs can bind within the peptide binding grooves of HLA-B*57:01, HLA-A*02:06 and HLA-A*02:03 alleles and thereby alter its specificity. In the docking simulations, the interactions were found between HLA-A*02:01 and sulfasalazine , streptomycin , oflaxacin at Asp54, Ile237, Glu236, Lys267, Glu256, Thr238 And Val255 with -6.43 kcal/mol, -5.86 kcal/mol and -5.83 kcal/mol binding energy. HLA-A*02:06, HLA-B*57:01 and HLA-A*02:03 have interaction with oflaxacin at Arg6, Lys58, Tyr51 and Arg72 with binding energies of -5.72 kcal/mol, -5.79 kcal/mol and -5.15 kcal/mol respectively.

Conclusion

The ultimate translation of this knowledge of how Anti-tuberculosis drugs interact with HLA would be applicable to preclinical drug screening programs to improve the safety and cost effectiveness of drug design and development.

Authors’ Affiliations

(1)
Department of Bioinformatics, Sathyabama University

Copyright

© Saxena and Christy; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement